Medtronic creeps toward FDA nod for drug-eluting balloon

By Damian Garde Medtronic ($MDT) has completed enrollment in the U.S. arm of a large-scale study for the IN.PACT Admiral, a device the company hopes to make the first drug-eluting ...

Recall charges drag down Stryker’s strong Q4 sales

Despite 5.5% revenue growth, net income tanked 32.7% By Damian Garde For Stryker ($SYK), the good news is it brought in $2.3 billion in fourth-quarter revenue, good for 5.5% growth ...

Hospital group: Stop passing the device tax down to providers

By Damian Garde The 2.3% excise tax on U.S. medical device sales has been in effect since Jan. 1, and hospital supply chain giant Novation claims at least one devicemaker has been ...

Covidien scores CE Mark for EverFlex peripheral stent, delivery system

By Editorial Staff Covidien has received CE Mark approval for its EverFlex self-expanding peripheral stent with Entrust delivery system. The Entrust delivery system is a one-handed ...

Atrial fibrillation: nContact wins FDA clearance for cardiac device

By MassDevice staff nContact gets a nod from the FDA for its next-generation cardiac device with added sensing technology.   nContact said it’s received FDA clearance for modifications ...

Annie’s Frozen Pizza Recall: Company Voluntarily Removes Products From Stores

BERKELEY, Calif. (AP) — Annie’s Inc. is voluntarily recalling seven kinds of frozen pizza sold nationwide over the possible risk that metal fragments made their way into the ...

Celgene’s Abraxane increases survival in pancreatic cancer

By Bill Berkrot (Reuters) – Celgene Corp said its Abraxane drug helped patients with advanced pancreatic cancer live an average of two months longer than chemotherapy and significantly ...

FDA Expands Approval For Novartis’ Exjade

The U.S. Food and Drug Administration on Wednesday expanded the approved use of Novartis AG’s (NVS: Quote) Exjade to treat patients ages 10 years and older who have chronic iron ...

Genentech’s Avastin approved for wider use in colorectal cancer

By Ron Leuty  Genentech Inc.’s top-selling cancer drug Avastin won approval from U.S. regulators Wednesday to expand its use for metastatic colorectal cancer patients. The ...

Quality Control Costs Tied to Drug Shortages

By Kathleen Struck Too little reward for manufacturing quality stands at the center of drug shortages involving sterile injectable generics, FDA officials asserted. Whereas brand manufacturers ...

St. Jude Medical Reports Fourth Quarter and Full-Year 2012 Results

By St. Jude Medical, Inc. ST. PAUL, Minn.–(BUSINESS WIRE)– St. Jude Medical, Inc. (STJ) today reported sales and net earnings for the fourth quarter and year ended December ...

Covidien snags CE mark for self-expanding stent

By Damian Garde Covidien ($COV) has picked up CE mark approval for its EverFlex self-expanding peripheral stent, a device outfitted with the company’s Entrust delivery system. ...
Page 32 of 55« First...1020...3031323334...4050...Last »
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS